+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etanercept"

From
Axial Spondyloarthritis Market - Global Forecast 2025-2030 - Product Thumbnail Image

Axial Spondyloarthritis Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Anti-Rheumatics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
From
From
TNF Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

TNF Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Psoriasis Biosimilar Market - Global Forecast 2025-2030 - Product Thumbnail Image

Psoriasis Biosimilar Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
From
From
From
TNF Alpha Inhibitors Market Report 2025 - Product Thumbnail Image

TNF Alpha Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Anti-Inflammatory Biologics Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Biologics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
From
Tumor Necrosis Factor Inhibitor Drugs Market Report 2025 - Product Thumbnail Image

Tumor Necrosis Factor Inhibitor Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Immunoglobulin Fusion Protein Global Market Report 2025 - Product Thumbnail Image

Immunoglobulin Fusion Protein Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Loading Indicator

Etanercept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein that works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation. Etanercept is administered by subcutaneous injection and is available in both brand name and generic forms. Etanercept is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other medications. It is generally well tolerated, with the most common side effects being injection site reactions, headache, and upper respiratory tract infections. The etanercept market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and Johnson & Johnson. Other companies in the market include Biogen, Merck, and Novartis. Show Less Read more